Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 11Gastrointestinal 10Thoracic 4Sarcoma 2Lymphoid 2Gynecologic 2Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Small Cell Lung Carcinoma 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Enoxaparin × Thoracic × Clear all
NCT01058759 2018-08-22

Taxotere-Enoxaparin-(ENOXA)-Study

Hannover Medical School

Phase 3 Terminated
14 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00717938 2017-08-25

RASTEN

Lund University Hospital

Phase 3 Completed
390 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00771563 2013-06-28

SYRINGES

University Hospital, Antwerp

Phase 3 Completed
104 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00916669 2013-05-08

A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Massachusetts General Hospital

Phase 2 Withdrawn
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡